WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, July 31, 2015, to discuss ImmunoGen’s financial results for the three-month period and fiscal year ended June 30, 2015 and its guidance for its 2016 fiscal year. Management also will provide an update on the Company.
Help employers find you! Check out all the jobs and post your resume.
